학술논문
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first‐line intensified treatment of pediatric patients with high‐risk acute lymphoblastic leukemia in CoALL08‐09 trial.
Document Type
Article
Author
Source
Pediatric Blood & Cancer; Dec2022, Vol. 69 Issue 12, p1-9, 9p
Subject
Language
ISSN
15455009